#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The Danger Signal S100B Integrates Pathogen– and Danger–Sensing Pathways to Restrain Inflammation


Humans inhale hundreds of Aspergillus conidia without adverse consequences. Powerful protective mechanisms may ensure prompt control of the pathogen and inflammation. Here we reveal a previously unknown mechanism by which the danger molecule S100B integrates pathogen– and danger–sensing pathways to restrain inflammation. Upon forming complexes with TLR2 ligands, S100B inhibited TLR2 via RAGE, through a paracrine epithelial cells/neutrophil circuit that restrained pathogen-induced inflammation. However, upon binding to nucleic acids, S100B activated intracellular TLRs eventually resolve danger-induced inflammation via transcriptional inhibition of S100B. Thus, the spatiotemporal regulation of TLRs and RAGE by S100B provides evidence for an evolving braking circuit in infection whereby an endogenous danger protects against pathogen–induced inflammation and a pathogen–sensing mechanism resolves danger–induced inflammation.


Vyšlo v časopise: The Danger Signal S100B Integrates Pathogen– and Danger–Sensing Pathways to Restrain Inflammation. PLoS Pathog 7(3): e32767. doi:10.1371/journal.ppat.1001315
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001315

Souhrn

Humans inhale hundreds of Aspergillus conidia without adverse consequences. Powerful protective mechanisms may ensure prompt control of the pathogen and inflammation. Here we reveal a previously unknown mechanism by which the danger molecule S100B integrates pathogen– and danger–sensing pathways to restrain inflammation. Upon forming complexes with TLR2 ligands, S100B inhibited TLR2 via RAGE, through a paracrine epithelial cells/neutrophil circuit that restrained pathogen-induced inflammation. However, upon binding to nucleic acids, S100B activated intracellular TLRs eventually resolve danger-induced inflammation via transcriptional inhibition of S100B. Thus, the spatiotemporal regulation of TLRs and RAGE by S100B provides evidence for an evolving braking circuit in infection whereby an endogenous danger protects against pathogen–induced inflammation and a pathogen–sensing mechanism resolves danger–induced inflammation.


Zdroje

1. GallucciS

MatzingerP

2001 Danger signals: SOS to the immune system. Curr Opin Immunol 13 114 119

2. JanewayCAJr

MedzhitovR

2002 Innate immune recognition. Annu Rev Immunol 20 197 216

3. DonatoR

2007 RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med 7 711 724

4. SchmidtAM

YanSD

YanSF

SternDM

2001 The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108 949 955

5. SparveroLJ

Asafu-AdjeiD

KangR

TangD

AminN

2009 RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 7 17

6. LinL

2006 RAGE on the Toll Road? Cell Mol Immunol 3 351 358

7. O'NeillLA

2006 How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 18 3 9

8. ChenGY

TangJ

ZhengP

LiuY

2009 CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323 1722 1725

9. LiuY

ChenGY

ZhengP

2009 CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns. Trends Immunol 30 557 561

10. SitkovskyMV

OhtaA

2005 The ‘danger’ sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol 26 299 304

11. BianchiME

2009 HMGB1 loves company. J Leukoc Biol 86 573 576

12. DonatoR

SorciG

RiuzziF

ArcuriC

BianchiR

2009 S100B's double life: intracellular regulator and extracellular signal. Biochim Biophys Acta 1793 1008 1022

13. GebhardtC

RiehlA

DurchdewaldM

NemethJ

FurstenbergerG

2008 RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 205 275 285

14. KaleaAZ

ReinigerN

YangH

ArrieroM

SchmidtAM

2009 Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. Faseb J 23 1766 1774

15. LeclercE

FritzG

WeibelM

HeizmannCW

GalichetA

2007 S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem 282 31317 31331

16. OstendorpT

LeclercE

GalichetA

KochM

DemlingN

2007 Structural and functional insights into RAGE activation by multimeric S100B. Embo J 26 3868 3878

17. LeclercE

FritzG

VetterSW

HeizmannCW

2009 Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta 1793 993 1007

18. IvanovS

DragoiAM

WangX

DallacostaC

LoutenJ

2007 A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110 1970 1981

19. TianJ

AvalosAM

MaoSY

ChenB

SenthilK

2007 Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8 487 496

20. YanaiH

BanT

WangZ

ChoiMK

KawamuraT

2009 HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462 99 103

21. ClynesR

MoserB

YanSF

RamasamyR

HeroldK

2007 Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response. Curr Mol Med 7 743 751

22. van ZoelenMA

SchoutenM

de VosAF

FlorquinS

MeijersJC

2009 The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. J Immunol 182 4349 4356

23. SegalBH

2009 Aspergillosis. N Engl J Med 360 1870 1884

24. AimaniandaV

BayryJ

BozzaS

KniemeyerO

PerruccioK

2009 Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 460 1117 1121

25. RomaniL

FallarinoF

De LucaA

MontagnoliC

D'AngeloC

2008 Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451 211 215

26. ChavakisT

BierhausA

Al-FakhriN

SchneiderD

WitteS

2003 The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198 1507 1515

27. ManfrediAA

CapobiancoA

EspositoA

De CobelliF

CanuT

2008 Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol 180 2270 2275

28. MoserB

DesaiDD

DownieMP

ChenY

YanSF

2007 Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo. J Immunol 179 8051 8058

29. ZelanteT

De LucaA

BonifaziP

MontagnoliC

BozzaS

2007 IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37 2695 2706

30. BonifaziP

D'AngeloC

ZagarellaS

ZelanteT

BozzaS

2010 Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. Mucosal Immunol 3 193 205

31. DonatoR

2003 Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 60 540 551

32. HuttunenHJ

Kuja-PanulaJ

SorciG

AgnelettiAL

DonatoR

2000 Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 275 40096 40105

33. HreggvidsdottirHS

OstbergT

WahamaaH

SchierbeckH

AvebergerAC

2009 The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 86 655 662

34. BellocchioS

MorettiS

PerruccioK

FallarinoF

BozzaS

2004 TLRs govern neutrophil activity in aspergillosis. J Immunol 173 7406 7415

35. MorettiS

BellocchioS

BonifaziP

BozzaS

ZelanteT

2008 The contribution of PARs to inflammation and immunity to fungi. Mucosal Immunol 1 156 168

36. SahayB

PatseyRL

EggersCH

SalazarJC

RadolfJD

2009 CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance. PLoS Pathog 5 e1000687

37. ShaQ

Truong-TranAQ

PlittJR

BeckLA

SchleimerRP

2004 Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol 31 358 364

38. BonizziG

KarinM

2004 The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25 280 288

39. PopovicPJ

DeMarcoR

LotzeMT

WinikoffSE

BartlettDL

2006 High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists. J Immunol 177 8701 8707

40. CollisonKS

ParharRS

SalehSS

MeyerBF

KwaasiAA

2002 RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol 71 433 444

41. ChaiLY

KullbergBJ

VonkAG

WarrisA

CambiA

2009 Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus. Infect Immun 77 2184 2192

42. BierhausA

HumpertPM

MorcosM

WendtT

ChavakisT

2005 Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83 876 886

43. HuttunenHJ

FagesC

RauvalaH

1999 Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 274 19919 19924

44. AdamiC

BianchiR

PulaG

DonatoR

2004 S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. Biochim Biophys Acta 1742 169 177

45. KajavaAV

VasselonT

2010 A network of hydrogen bonds on the surface of TLR2 controls ligand positioning and cell signaling. J Biol Chem 6227 6234

46. HeizmannCW

FritzG

SchaferBW

2002 S100 proteins: structure, functions and pathology. Front Biosci 7 d1356 1368

47. GuiducciC

OttG

ChanJH

DamonE

CalacsanC

2006 Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J Exp Med 203 1999 2008

48. HondaK

OhbaY

YanaiH

NegishiH

MizutaniT

2005 Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434 1035 1040

49. Ramirez-OrtizZG

SpechtCA

WangJP

LeeCK

BartholomeuDC

2008 Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect Immun 76 2123 2129

50. BozzaS

PerruccioK

MontagnoliC

GazianoR

BellocchioS

2003 A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 102 3807 3814

51. KarikoK

NiH

CapodiciJ

LamphierM

WeissmanD

2004 mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279 12542 12550

52. AksoyE

ZouainCS

VanhoutteF

FontaineJ

PavelkaN

2005 Double-stranded RNAs from the helminth parasite Schistosoma activate TLR3 in dendritic cells. J Biol Chem 280 277 283

53. CavassaniKA

IshiiM

WenH

SchallerMA

LincolnPM

2008 TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 205 2609 2621

54. CastetsF

GriffinWS

MarksA

Van EldikLJ

1997 Transcriptional regulation of the human S100 beta gene. Brain Res Mol Brain Res 46 208 216

55. CaiW

HeJC

ZhuL

LuC

VlassaraH

2006 Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor. Proc Natl Acad Sci U S A 103 13801 13806

56. VivesV

AlonsoG

SolalAC

JoubertD

LegraverendC

2003 Visualization of S100B-positive neurons and glia in the central nervous system of EGFP transgenic mice. J Comp Neurol 457 404 419

57. YouY

RicherEJ

HuangT

BrodySL

2002 Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population. Am J Physiol Lung Cell Mol Physiol 283 L1315 1321

58. SorciG

RiuzziF

AgnelettiAL

MarchettiC

DonatoR

2003 S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol Cell Biol 23 4870 4881

59. SoderbergO

GullbergM

JarviusM

RidderstraleK

LeuchowiusKJ

2006 Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 3 995 1000

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2011 Číslo 3
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#